Hepatitis B immunoglobulin (Banghe Pharmaceutical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B immunoglobulin (Banghe Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2013/03/26
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBanghe Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesZhengzhou Seastar Banghe Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A